Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vasilakis-Scaramozza

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|November 14, 2001
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptivesC Vasilakis-Scaramozza, H Jick
British Journal of Clinical Pharmacology|October 27, 2001
Live attenuated polio vaccine and the risk of intussusceptionH Jick, C Vasilakis-Scaramozza, S S Jick
Archives of Dermatology|October 13, 2000
Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicideS S Jick, H M Kremers, C Vasilakis-Scaramozza
Pharmacotherapy|June 15, 2000
Incidence of first-time idiopathic seizures in users of tramadolC Gasse, L Derby, C Vasilakis-Scaramozza, et al.
Epidemiology (Cambridge, Mass.)|March 15, 2001
The risk of cataract among users of inhaled steroidsS S Jick, C Vasilakis-Scaramozza, W C Maier
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2020
The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan databaseC Vasilakis-Scaramozza, R Persson, K W Hagberg, et al.
BMJ (Clinical Research Ed.)|November 10, 2000
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisH Jick, J A Kaye, C Vasilakis-Scaramozza, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 14, 2001
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptivesC Vasilakis-Scaramozza, H Jick
British Journal of Clinical Pharmacology|October 27, 2001
Live attenuated polio vaccine and the risk of intussusceptionH Jick, C Vasilakis-Scaramozza, S S Jick
Archives of Dermatology|October 13, 2000
Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicideS S Jick, H M Kremers, C Vasilakis-Scaramozza
Pharmacotherapy|June 15, 2000
Incidence of first-time idiopathic seizures in users of tramadolC Gasse, L Derby, C Vasilakis-Scaramozza, et al.
Epidemiology (Cambridge, Mass.)|March 15, 2001
The risk of cataract among users of inhaled steroidsS S Jick, C Vasilakis-Scaramozza, W C Maier
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2020
The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan databaseC Vasilakis-Scaramozza, R Persson, K W Hagberg, et al.
BMJ (Clinical Research Ed.)|November 10, 2000
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisH Jick, J A Kaye, C Vasilakis-Scaramozza, et al.
Pageof 1